Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region

Hepatology

Volumn 33, Issue 3, 2001, Pages 751-757

  Stuyver, Lieven J ^a,b   Locarnini, Stephen A ^c   Lok, Anna ^d   Richman, Douglas D ^e   Carman, William F ^f   Dienstag, Jules L ^g   Schinazi, Raymond F ^h  

^a ATLANTA VA MEDICAL CENTER   (United States)

^b PHARMASSET INC   (United States)

^c VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; INTEGRASE; LAMIVUDINE; PROTEIN; PROTEINASE; RNA DIRECTED DNA POLYMERASE; RNA POLYMERASE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CODON; ENZYME ACTIVITY; GENE EXPRESSION; GENE MUTATION; GENOTYPE; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOHEPADNAVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION;

EID: 17744375593     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.22166     Document Type: Article

References (70)

1. Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients
2. Lamivudine as initial treatment for chronic hepatitis B in the United States
3. Clinical relevance of hepatitis B viral mutations
4. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B
5. A one-year trial of lamivudine for chronic hepatitis B
6. Selection of mutations in the hepatitis B virus polymerasc during therapy of transplant recipients with lamivudine
7. High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation
8. Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors
9. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation
10. Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B
11. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation
12. Significance of mutations in the hepatitis B virus polymerase selected by nucleoside analogues and implications for controlling chronic disease
13. Mutations in the hepatitis B virus DNA polymerase associated with antiviral resistance
14. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes
15. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes
16. Cloning and structural analyses of hepatitis B virus DNAs, sub-type adr
17. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
18. Nucleotide sequence of a cloned hepatitis B virus genome, sub-type ayr: Comparison with genomes of the other three subtypes
19. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness
20. Unique preS sequence in a gibbon-derived hepatitis B virus variant
21. Complete sequencing of a gibbon hepatitis B virus genome reveals a unique geno-type distantly related to the chimpanzee hepatitis B virus
22. The complete nucleotide sequence of the genome of a hepatitis B virus isolated from a naturally infected chimpanzee
23. Hepatitis B outbreak among chimpanzees at the London Zoo
24. Molecular epidemiology of hepatitis B virus variants in non-human primates
25. A new group of hepadnaviruses naturally infecting orangutans (Pongo pygmaeus)
26. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): Phylogenetic relationships with human and other primate genotypes
27. Relationships between serotypes and genotypes of hepatitis B virus: Genetic classification of HBV by use of surface genes
28. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns
29. Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: Possible contribution of a single nucleotide in the precore region
30. Polymerase chain reaction can resolve some undefined cases of hepatitis B virus antigenic subtyping
31. Typing of hepatius B virus genomes by a simplified polymerase chain reaction
32. A line probe assay for hepatitis B virus genotypes
33. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela
34. Hepatitis B defective virus with rearrangements in the preS gene during chronic HBV infection
35. PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection
36. Hepatitis B virus replication - An update
37. Hepatitis B virus replication: Novel roles for virus-host interactions
38. The effects of dNTP pool imbalances on frameshift fidelity during DNA replication
39. A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells
40. Evidence for involvement of a ribosomal leaky scanning mechanism in the translation of the hepatitis B virus pol gene from the viral pregenome RNA
41. Translation of the hepatitis B virus P gene by ribosomal scanning as an alternative to internal initiation
42. Translational regulation of hepatitis B virus polymerase gene by termination-reinitiation of an upstream minicistron in a length-dependent manner
43. Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction
44. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription
45. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase
46. Mutational analysis of the hepatitis B virus P gene product: Domain structure and RNase H activity
47. Hepatitis B virus: DNA polymerase activity of deletion mutants
48. Decreased replication capacity of a duck hepatitis B virus mutant with altered distal pre-S region
49. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site
50. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements
51. Expression, purification, and characterization of an active RNase H domain of the hepatitis B viral polymerase
52. Viral dynamics in hepatitis B virus infection
53. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences
54. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G→A hypermutation
55. G→A hypermutation of the human immunodeficiency virus type 1 genome: Evidence for dCTP pool imbalance during reverse transcription
56. Vaccine-induced escape mutant of hepatitis B virus
57. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant
58. Nucleotide sequence of a cloned woodchuck hepatitis virus genome: Comparison with the hepatitis B virus sequence
59. A new hepadnavirus endemic in arctic ground squirrels in Alaska
60. Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus
61. PreS1 deleted variants of hepatitis B virus in patients with chronic hepatitis
62. Isolation of a hepadnavirus from the woolly monkey, a New World primate
63. Mutations in retroviral genes associated with drug resistance: 2000-2001 update
64. Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B
65. A placebo-controlled phase I/II study of adefovir dipivoxil in patients with chronic hepatitis B virus infection
66. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: A randomized controlled trial
67. In vitro evaluation of hepatitis B virus polymerase mutations associated with famciclovir resistance
68. Structure of a covalently trapped catalytic complex of HIVreverse transcriptase: Implications for drug resistance
69. A line probe assay for monitoring drug-resistance in HBV-infected patients during antiviral therapy